Fabrication of thermoresponsive nanogels by thermo-nanoprecipitation and in
situ encapsulation of bioactives by Giulbudagian, Michael et al.
Registered charity number: 207890
Showcasing research from the ThermoNanogel Research Group 
of Prof. Marcelo Calderón at the Institute of Chemistry and 
Biochemistry, Department of Biology, Chemistry, Pharmacy, 
Freie Universität Berlin, Germany.
Fabrication of thermoresponsive nanogels by thermo-
nanoprecipitation and in situ encapsulation of bioactives 
Thermo-nanoprecipitation (TNP) is presented as a versatile, 
surfactant-free, and mild synthetic method for the preparation 








Brent S. Sumerlin et al.
Oximes as reversible links in polymer chemistry: dynamic macromolecular 
stars
Volume 5 Number 24 21 December 2014 Pages 6869–7136
As featured in:
See Marcelo Calderón et al. 




Cite this: Polym. Chem., 2014, 5,
6909
Received 27th August 2014,
Accepted 12th September 2014
DOI: 10.1039/c4py01186d
www.rsc.org/polymers
Fabrication of thermoresponsive nanogels
by thermo-nanoprecipitation and in situ
encapsulation of bioactives†
Michael Giulbudagian,‡a Mazdak Asadian-Birjand,‡a Dirk Steinhilber,a
Katharina Achazi,a Maria Molinaa and Marcelo Calderón*a,b
A synthetic method for thermoresponsive, glycerol based nanogels
has been developed. The nanogels were synthesized by nanopreci-
pitation of the orthogonally functionalized macromonomers and
their gelation in water. The crosslinking points were generated by
strain promoted azide–alkyne cycloaddition which enabled the
in situ encapsulation of Doxorubicin HCl. The mild and surfactant
free reaction conditions make these nanogels ideal candidates for
biomedical applications.
The term nanogel (NG) refers to nanometer sized crosslinked
polymeric networks. Such networks reveal intrinsic properties,
such as high water content, soft nature, cell and tissue compati-
bility, and excellent water dispersability/solubility.1–3 Therefore
NGs are mainly developed as drug carriers which shrink or
swell significantly by expelling or absorbing large amounts of
water. NGs that respond to environmental stimuli like
temperature, pH, and light facilitate the controlled release of
the encapsulated drug cargo in a specific site of action upon
environmental triggers.1,4 Among such stimuli, temperature is
attractive due to its simple accessibility and applicability both
in vitro and in biological environment.5,6
The building blocks of such nanostructures are of main
importance when considering biomedical applications. Poly-
ethers like linear thermoresponsive polyglycerol (tPG) and den-
dritic polyglycerol (dPG) are good candidates due to their
biocompatible profile7–9 and their tunable character.10–13 tPG,
based on glycidyl methyl ether (GME) and ethyl glycidyl ether
(EGE), exhibits cloud point temperatures (Tcp) and undergoes
a coil-to-globule phase transition. Their Tcp, which depends
on the incorporated GME/EGE monomer ratio, is adjustable in
the range between 15–57 °C.14–16 Additionally, the tunable size
and the multifunctional surface of dPG enable diverse modifi-
cations to control their properties in terms of chemical reacti-
vity, solubility, charge, and biocompatibility.10,17
The synthesis of NGs is typically based on templates which
aﬀord the generation of a crosslinked network in a confined
space. Such network formation is accomplished by the
polymerization of monomers in the presence of a crosslinker
or alternatively by crosslinking of pre-synthesized polymer
chains.2 Emulsion and dispersion/precipitation polymeri-
zations have been widely utilized for the synthesis of thermo-
responsive NGs (tNGs).18,19 Such techniques may require the
use of surfactants and high shear stress. Our group has
demonstrated that radical polymerization can be used for the
synthesis of tNGs based on dPG.18,20 However, radical cross-
linking procedures may be unfavorable for the in situ incorpor-
ation of sensitive bioactives. Recently a method was developed
by Haag et al. which allowed the surfactant free synthesis
of degradable NGs by the so-called inverse nanoprecipitation
method using a variety of gelation chemistries.21,22 This
technique showed high encapsulation properties and a release
of active biomacromolecules in acidic environments. Further-
more, a hydrogel construction kit has been developed
for the bioorthogonal encapsulation and pH-controlled release
of living cells.23
In this paper we describe for the first time a new concept to
easily generate tNGs while remaining mild, surfactant free,
and with the potential to precisely tune the length between the
crosslinking points by choosing a polymer of a certain mole-
cular weight. The crosslinked network could be generated by
nanoprecipitation through orthogonal strain-promoted azide–
alkyne cycloaddition (SPAAC), which enabled the selective
ligation with minimum purification steps and in situ incorpor-
ation of bioactives. The nanoprecipitation method refers to a
simple procedure to form polymeric nanoparticles by the pre-
cipitation of a dissolved material upon an exposure to a non-
solvent.24
The water soluble macro-crosslinker, cyclooctyne modified
dendritic polyglycerol (dPG-Oct), and the thermoresponsive
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macromonomer, azide functionalized tPG (N3-tPG-N3), were
solubilized in dimethylformamide (DMF) and precipitated in
water at 45 °C (Fig. 1). Considering the excellent solubility of
the tPG in a wide variety of solvents, we took advantage of its
thermoresponsive behaviour to precipitate it in water, above its
transition temperature. Since the precipitation of the polymer
occurs due to its thermoresponsive behaviour rather than by
using a typical non-solvent, we call this novel approach
thermo-nanoprecipitation (TNP). Moreover, to enhance the
hydrophobicity of the dPG and induce its co-precipitation with
tPG, 7 to 28 free hydroxyl groups were functionalized with
cyclooctyne functionalities.
The selection of the solvent/non-solvent on the other hand
plays a critical role when one intends to encapsulate drugs in
situ particle formation. The careful selection of the solvent for
such systems dictates which drugs can be encapsulated within
the tNGs as the drug itself has to be soluble in the selected
solvent. In such manner the drug would interact with the
macro-molecules when injected into the non-solvent and be
entrapped in the formed crosslinked network.
The tNG’s responsive behaviour, polydispersity, and
potential for biomedical applications were studied. The
developed method can potentially serve as a universal
template for preparing tNGs from diﬀerent thermoresponsive
polymers.
A rational screening of the synthetic conditions was per-
formed to explore the potential of the technique to yield par-
ticles with diﬀerent sizes and transition temperatures. Table 1
summarizes the synthetic conditions. Particles with a narrow
size distribution could be obtained by TNP in water, which
served as a non-solvent. Generally, dPG-Oct with an average
molecular weight of 10 kDa with 7, 14, or 28 functional groups
was coprecipitated with N3-tPG-N3 of 5 kDa or 15 kDa. DMF
was used as solvent and water at 45 °C as non-solvent,
while the concentration of the macromonomers and the ratio
between the solvent and the non-solvent were optimized to
aﬀord the formation of a stable dispersion. The stability of the
dispersion, in terms of coalescence and Ostwald ripening, was
critical allowing the crosslinking reaction to proceed to com-
pletion. The remaining unreacted cyclooctyne functionalities
were quenched with azidopropanol or alternatively, with an
azide functionalized cyanin dye (Cy5) as fluorescent label
for further biological studies. Detailed synthetic conditions
are described in the ESI.†
Fig. 1 Schematic representation of nanogel synthesis by thermo-nanoprecipitation (TNP) of N3-tPG-N3 and dPG-Oct.
Table 1 Summary of tNG synthetic conditions
Solvent (S)
Non-solvent











DMF H2O (T > Tcp) 1 : 20 5, 15 10 2–24 91–331, (0.06–0.26)
aDetermined by GPC. b Total concentration of the macromonomers in the solvent (DMF). c Polydispersity index (PDI) determined by DLS at
25 °C, average of 3 measurements from the intensity distribution curves.
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The crosslinking reaction could be monitored by FT-IR
spectroscopy which confirmed the disappearance of the
azide signal at 2099 cm−1 indicating triazole formation
through strain promoted cycloaddition of tPG-Oct and tPG-
azide. To verify the chemical crosslinking, a control exper-
iment using macromonomers without crosslinking functional-
ities was performed. After the TNP the reaction crude was
dissolved in DMF, and measured by DLS. Sizes of about
5–10 nm could be observed by DLS, which correspond to
the polymeric precursors and indicate that no tNGs were
formed.
Moreover, tNGs were characterized by dynamic light scatter-
ing (DLS), atomic force microscopy (AFM), transmission elec-
tron microscopy (TEM), and nanoparticle tracking analysis
(NTA). These techniques confirmed the formation of spherical
particles with narrow size distribution. As an example, AFM
image of tNG is shown in Fig. 2a. While by DLS particles of
∼100 nm of diameter could be determined, by AFM the mean
particle size was determined to be smaller (∼60 nm) due to the
partial deswelling of the particles on the mica surface at
ambient conditions. However, TEM measurement of the tNGs
in terms of size and morphology confirmed the formation of
spherical particles of ∼100 nm (Fig. 2b). In order to comp-
lement the DLS measurements tNG was also analysed by NTA
and diﬀusion-ordered NMR spectroscopy (DOSY). The dia-
meter measured at 25 °C by DLS for a tNG with diameter of
180.3 nm (PDI 0.07) correlated with the one measured by NTA
(173.3 nm, standard deviation 4.23 nm, PDI 0.006). Both tech-
niques showed monomodal distributions and low size disper-
sity. In DOSY measurements a range of sizes was observed,
however diﬀusion coeﬃcients corresponding to particles with
diameters of about 130 nm were predominantly found. The
size dispersity did not allow to explicitly determine a diameter
value for the tNGs. Additionally, NTA enabled evaluating the
particle concentration and therefore, estimating the molecular
weight of the tNG. A concentration of 1.69 × 108 particles mL−1
was measured which corresponds to an apparent molecular
weight of 71.24 MDa.
Previous reports of particles formed by the nanoprecipita-
tion technique showed that smaller sized particles were
obtained when low polymer concentrations were used and that
the size increased with increasing concentration of the
polymers in the solvent.21,25 Contrary to this observation, our
concentration dependent analysis, performed by DLS measure-
ments, showed no significant size change for the tNGs by
varying the macromonomer concentration from 2 up to 24 mg
mL−1 while keeping the dPG-Oct feed ratio constant
(Table S1,† tNG04–tNG09). This interesting feature would
allow the tailoring of NGs, which incorporate bioactives in situ,
without losing the desired nanometric sizes and responsive-
ness. In addition, no tendency in size was observed for tNGs
prepared with tPG of 5 kDa while increasing the dPG-Oct feed
ratio, or modifying the molecular weight of the tPG. It is note-
worthy that the synthetic method was found to be reproducible
under same conditions (±7 nm, out of 3 preparations),
however the physico-chemical properties of the tNGs and the
control over them are currently under investigation. The tNGs
remained stable in a solution kept over a period of at least
3 month at 6 °C.
The thermoresponsive behaviour was analyzed by UV-Vis
transmittance measurements for full characterization of the
tNGs. Tcp values of about 30 °C were observed for all tNGs at
1 mg mL−1, when a thermoresponsive polymer of 1 : 1 ratio of
GME and EGE was used for the synthesis. As it was expected,
these values are about 3 °C higher when compared with the
Tcp values of the corresponding tPG as shown in Fig. 2c (solid
lines compared with dashed lines). This phenomenon can be
attributed to higher hydrophilic character induced by the dPG
upon crosslinking. Furthermore, comparison of polymer and
tNG solutions of diﬀerent concentrations revealed concen-
tration dependent phase transition behaviour. A decrease of
3 °C was observed upon elevated concentrations, when the
transmittance was measured for 0.25, 0.5, and 1 mg mL−1 solu-
tions (Fig. 2c, red, blue, and green lines). Such behaviour can
be related to enhanced interactions between the polymer
chains at higher concentrations. Thus, both the concentration
dependent Tcp, as well as the adjustable nature of the tPG
through tailorable GME/EGE ratios in the polymer chain,
can be easily applied to finely tune the Tcp of the tNGs for a
desired application.
Fig. 2 Characterization of tNGs. (a) AFM statistical analysis of the inserted AFM image. (b) TEM image of tNGs. (c) Normalized transmittance of tNG
solution (solid lines) and corresponding thermoresponsive precursors, tPG (dashed lines), in PBS as a function of temperature at 0.25 mg mL−1
(green), 0.5 mg mL−1 (blue), and 1 mg mL−1 (red).
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To demonstrate the encapsulation ability of the tNG Doxo-
rubicin HCl (Dox) was chosen as an anti-cancer drug model.
Dox was dissolved in DMF together with the polymeric precur-
sors and co-precipitated in water to form the tNG. The loaded
tNGs were purified from the free Dox using a centrifugal filter
device and the loading was determined by UV-Vis (λ = 488 nm)
to be 52.40 wt%. Such an encapsulation technique may ensure
the entrapment of the encapsulated moiety within the nano-
carrier rather than being adsorbed on its surface. Moreover, it
enables high encapsulation eﬃciencies and a homogenous
distribution of the guest within the nanocarrier.26 Moreover,
the size of the loaded carrier (104 nm, PDI 0.29, mean of two
experiments), analysed by DLS, was found to be similar to the
size of tNG prepared by the corresponding route.
As the tNGs show potential as drug delivery systems, e.g. for
cancer treatment, the cytotoxicity of tNG was exemplarily evalu-
ated in adenocarcinomic human alveolar basal epithelial
(A549) tumor cells by real time cell analysis (RTCA) measure-
ments and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide) assay. Up to a concentration of 2 mg mL−1
no cytotoxicity could be observed in the MTT assay as well
as in the RTCA measurements after 72 h treatment (Fig. 3a).
Furthermore, RTCA measurement showed no decrease in
viability for 24 and 48 h post treatment (data not shown).
Internalization of tNGs by tumor cells, which is important
for later use as a drug carrier, was verified by confocal
microscopy (Fig. 3b–d). Cy5-labeled tNGs could be observed in
cellular compartments of A549 cells treated for 18 h. The tNGs
particularly accumulated in the perinuclear region. However,
no tNG was found in the nucleus and no co-localization
of tNG-Cy5 with early endosomes has been observed.
Conclusions
In summary, we have presented a versatile, surfactant-free, and
mild synthetic method, which is named TNP and is used for
the preparation of tNGs crosslinked by copper-free click
chemistry. These tNGs have shown low cytotoxicity with excel-
lent cellular penetration properties. The use of pre-synthesized
polymers allowed us to precisely control the transition temp-
erature of the tNGs by controlling the GME/EGE ratio of the
tPG. The conditions of this synthetic method provide an
eﬀective approach to yield a library of thermoresponsive nano-
carriers via a simple and biocompatible route. Dox could be
successfully encapsulated in situ particle formation with a
high loading eﬃciency. The ability of the tNGs to release
the encapsulated payload upon a thermal trigger in biological
models is currently under investigation. Furthermore, the
potential of tuning the size of the carriers by modifying the
polymer chain length and the crosslinking density are being
evaluated as a tool to achieve desired release kinetics.
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